ISHO founder Wang Teng unveils ISHO Intelligence sleep-health AI system
At the ISHO 今日宜休 AI sleep-technology ecosystem launch on October 29, founder Wang Teng announced a company strategy to build ISHO Intelligence, a sleep-health AI technology system for individuals, combining sleep science, AI algorithms and hardware-software product development. Wang Teng said the company will focus on precise monitoring, scientific intervention and energy recovery, and plans to collect more than 1,000 gold-standard clinical PSG samples within one year. He also said the research scope of sleep products is expanding from nighttime sleep quality to daytime energy and other post-wake scenarios.
The ISHO Intelligence strategy and the target of over 1,000 clinical PSG samples give the startup's AI sleep-health program a measurable data foundation, though the collection outcome and any clinical validation remain unconfirmed.
IT之家 10 月 29 日现场消息，在今晚的 ISHO 今日宜休 AI 睡眠科技生态产品发布会上，公司创始人王腾首次发布会公布公司战略：以专业睡眠科学、AI 算法与软硬件产品研发协同，构建面向个人的睡眠健康 AI 技术体系 ISHO Intelligence。
王腾表示，今日宜休聚焦精准监测、科学干预与精力恢复，计划一年内采集超 1000 例金标准临床 PSG 数据。他透露。睡眠产品的科研范畴正从夜间睡眠质量，延伸至日间精力状态等醒后场景。
IT之家注：PSG 全称为多导睡眠监测，是一种通过同步记录整夜睡眠中的脑电、眼电、肌电、心电、呼吸运动、血氧饱和度等多项生理参数的无创检查技术。
该技术可客观评估睡眠结构、呼吸暂停时长与频率、血氧下降程度及肢体运动状态，为阻塞性睡眠呼吸暂停低通气综合征、发作性睡病、周期性肢体运动障碍等睡眠相关疾病的确诊提供量化依据。
